Cabaletta Bio (CABA) Research & Development (2018 - 2025)

Cabaletta Bio's Research & Development history runs 8 years deep, the most recent figure standing at $140.8 million for Q4 2025.

• On a quarterly basis, Research & Development rose 512.15% year-over-year to $140.8 million in Q4 2025; TTM through Dec 2025 was $179.6 million, a 145.67% increase from a year earlier, with the FY2025 full-year figure at $142.7 million, up 46.78% from the prior year.
• Research & Development advanced to $140.8 million in Q4 2025 per CABA's latest filing, from $578000.0 in the prior quarter.
• Across five years, Research & Development topped out at $140.8 million in Q4 2025 and bottomed at -$36.6 million in Q4 2023.
• The 5-year median for Research & Development is $9.7 million (2021), against an average of $16.3 million.
• Across the five-year window, Research & Development tumbled 395.48% in 2023 and surged 512.15% in 2025, its largest moves.
• Year by year, Research & Development stood at $9.9 million in 2021, then rose by 25.01% to $12.4 million in 2022, then slumped by 395.48% to -$36.6 million in 2023, then soared by 162.77% to $23.0 million in 2024, then jumped by 512.15% to $140.8 million in 2025.
• Per Business Quant, the three latest CABA Research & Development figures stand at $140.8 million (Q4 2025), $578000.0 (Q3 2025), and $37.6 million (Q2 2025).